儿童 2019 年新型冠状病毒感染的诊断、治疗和预防：专家共识。
Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement.
机构信息
Department of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.
出版信息
World J Pediatr. 2020 Jun;16(3):223-231. doi: 10.1007/s12519-020-00343-7. Epub 2020 Feb 7.
Abstract
Since the outbreak of 2019 novel coronavirus infection (2019-nCoV) in Wuhan City, China, by January 30, 2020, a total of 9692 confirmed cases and 15,238 suspected cases have been reported around 31 provinces or cities in China. Among the confirmed cases, 1527 were severe cases, 171 had recovered and been discharged at home, and 213 died. And among these cases, a total of 28 children aged from 1 month to 17 years have been reported in China. For standardizing prevention and management of 2019-nCoV infections in children, we called up an experts' committee to formulate this experts' consensus statement. This statement is based on the Novel Coronavirus Infection Pneumonia Diagnosis and Treatment Standards (the fourth edition) (National Health Committee) and other previous diagnosis and treatment strategies for pediatric virus infections. The present consensus statement summarizes current strategies on diagnosis, treatment, and prevention of 2019-nCoV infection in children.
摘要
截至 2020 年 1 月 30 日，自中国武汉市发生 2019 年新型冠状病毒感染（2019-nCoV）疫情以来，中国 31 个省（区、市）累计报告确诊病例 9692 例，疑似病例 15238 例。确诊病例中，死亡 213 例，治愈出院 171 例，现有重症病例 1527 例。在确诊病例中，中国报告有 28 例儿童病例，年龄最小为 1 月龄，最大为 17 岁。为规范儿童 2019 年新型冠状病毒感染的防控管理，我们召集专家委员会制定本专家共识。本共识以《新型冠状病毒感染的肺炎诊疗方案（试行第四版）》（国家卫生健康委员会）和以往小儿病毒感染的诊疗策略为基础。本共识总结了目前儿童 2019-nCoV 感染的诊断、治疗和预防策略。
相似文献
1
Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement.儿童 2019 年新型冠状病毒感染的诊断、治疗和预防：专家共识。
World J Pediatr. 2020 Jun;16(3):223-231. doi: 10.1007/s12519-020-00343-7. Epub 2020 Feb 7.
2
[Chinese experts' consensus on diagnosis and treatment of severe and critical coronavirus disease 2019 (revised edition)].《新型冠状病毒肺炎重型、危重型病例诊疗中国专家共识（修订版）》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):269-274. doi: 10.3760/cma.j.cn121430-20200218-00188.
3
Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition).儿童新型冠状病毒肺炎诊疗和预防相关问题专家共识（第二版简化版）
World J Pediatr. 2020 Jun;16(3):232-239. doi: 10.1007/s12519-020-00362-4. Epub 2020 Apr 24.
4
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.儿童 SARS-CoV-2 感染诊断和治疗建议更新。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2211-2223. doi: 10.1007/s10096-020-03973-x. Epub 2020 Aug 6.
5
COVID-2019: update on epidemiology, disease spread and management.2019冠状病毒病：流行病学、疾病传播及管理的最新情况
Monaldi Arch Chest Dis. 2020 Apr 16;90(1). doi: 10.4081/monaldi.2020.1292.
6
[Discussion and suggestion on the classification of severe and critical coronavirus disease 2019 in Chinese experts' consensus on diagnosis and treatment of severe and critical coronavirus disease 2019].《新型冠状病毒肺炎重型、危重型病例分类的讨论与建议——新型冠状病毒肺炎重型、危重型病例诊疗中国专家共识》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):277. doi: 10.3760/cma.j.cn121430-20200226-00339.
7
[Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China].中国北方六省（自治区）31例儿童2019新型冠状病毒感染的临床分析
Zhonghua Er Ke Za Zhi. 2020 Apr 2;58(4):269-274. doi: 10.3760/cma.j.cn112140-20200225-00138.
8
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.针对源自中国武汉的肺炎疫情的新型冠状病毒感染的诊断和治疗措施。
Microbes Infect. 2020 Mar;22(2):74-79. doi: 10.1016/j.micinf.2020.01.003. Epub 2020 Feb 1.
9
Case analysis of novel coronavirus pneumonia in the Second Hospital of Wuhan Iron and Steel Company, Qingshan District, Wuhan, China.中国武汉青山区武汉钢铁公司第二医院新型冠状病毒肺炎病例分析
Ann Palliat Med. 2020 Jul;9(4):2193-2202. doi: 10.21037/apm-20-1372. Epub 2020 Jul 20.
10
COVID-19 pandemic; prevention, treatment, and mental health.2019冠状病毒病大流行；预防、治疗与心理健康
Hum Vaccin Immunother. 2020 Sep 1;16(9):2215-2216. doi: 10.1080/21645515.2020.1759976. Epub 2020 May 21.
引用本文的文献
1
Coronavirus in Recent Years: Characteristics, Outbreaks, and Treatments.近年来的冠状病毒：特征、疫情及治疗方法
Tanaffos. 2024 Mar;23(3):220-237.
2
Risk Factors and Clinical Features of Deterioration in 739 COVID-19 Affected Children Aged Under 14 Years in Zhuhai, China: A Multicenter, Retrospective Study.中国珠海739例14岁以下新冠病毒感染儿童病情恶化的危险因素及临床特征：一项多中心回顾性研究
Pediatr Discov. 2025 May 19;3(2):e70001. doi: 10.1002/pdi3.70001. eCollection 2025 Jun.
3
Design of a Universal Backbone Improving the Endonuclease Dependence Molecular Beacon Assay.一种改进核酸内切酶依赖性分子信标分析的通用骨架设计
ACS Omega. 2025 Jun 18;10(25):27174-27181. doi: 10.1021/acsomega.5c02447. eCollection 2025 Jul 1.
4
COVID-19 herd immunity in Lebanon: Challenges and prospects.黎巴嫩的新冠病毒群体免疫：挑战与前景
Public Health Chall. 2024 Mar 20;3(1):e167. doi: 10.1002/puh2.167. eCollection 2024 Mar.
5
[Multisystemic inflammatory syndrome in children with COVID-19: a rheumatology perspective].[新型冠状病毒肺炎患儿的多系统炎症综合征：风湿病学视角]
Rev Colomb Reumatol. 2021 Oct-Dec;28(4):289-299. doi: 10.1016/j.rcreu.2020.09.005. Epub 2020 Oct 17.
6
An overview of SARS-CoV-2 transmission and engineering strategies to mitigate risk.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）传播概述及降低风险的工程策略。
J Build Eng. 2023 Aug 15;73:106737. doi: 10.1016/j.jobe.2023.106737. Epub 2023 May 8.
7
Evaluating the impact of COVID-19 on cancer care: a comprehensive analysis of treatment modifications, risk factors, and patient outcomes.评估2019冠状病毒病对癌症护理的影响：对治疗调整、风险因素和患者结局的综合分析。
BMC Infect Dis. 2025 Jun 2;25(1):779. doi: 10.1186/s12879-025-11172-2.
8
Clinical and laboratory markers defining MIS-C and hyperinflammation in COVID-19: a cross-sectional study in a tertiary hospital.定义COVID-19中儿童多系统炎症综合征和过度炎症的临床及实验室指标：一项三级医院的横断面研究
Adv Rheumatol. 2025 Mar 17;65(1):16. doi: 10.1186/s42358-025-00447-6.
9
Mental health problems and associated factors of students at different learning stages during and after COVID-19 pandemic in Sichuan, China.中国四川省新冠疫情期间及之后不同学习阶段学生的心理健康问题及相关因素
BMC Psychiatry. 2025 Feb 18;25(1):144. doi: 10.1186/s12888-025-06588-8.
10
A cross-sectional study of parental perspectives on children about COVID-19 and classification using machine learning models.一项关于父母对儿童 COVID-19 看法及使用机器学习模型进行分类的横断面研究。
Front Public Health. 2025 Jan 15;12:1373883. doi: 10.3389/fpubh.2024.1373883. eCollection 2024.
本文引用的文献
1
[Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (Trial version 1)].《湖北省儿童新型冠状病毒感染诊疗推荐（试行第一版）》
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Feb;22(2):96-99. doi: 10.7499/j.issn.1008-8830.2020.02.003.
2
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
3
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
4
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例，提示存在人际传播：一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
5
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
6
Global virus outbreaks: Interferons as 1st responders.全球病毒爆发：干扰素作为第一反应者。
Semin Immunol. 2019 Jun;43:101300. doi: 10.1016/j.smim.2019.101300.
7
Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy.I 型干扰素在婴儿期增强呼吸道合胞病毒感染的 IgA 免疫。
Sci Rep. 2018 Jul 23;8(1):11034. doi: 10.1038/s41598-018-29456-w.
8
Middle East respiratory syndrome coronavirus in children.儿童中的中东呼吸综合征冠状病毒
Saudi Med J. 2015 Apr;36(4):484-6. doi: 10.15537/smj.2015.4.10243.
9
[Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro].重组人干扰素α2b体外抗呼吸道病毒广谱药效学研究
Yao Xue Xue Bao. 2014 Nov;49(11):1547-53.
10
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.利巴韦林与干扰素治疗中东呼吸综合征冠状病毒感染患者的一项观察性研究。
Int J Infect Dis. 2014 Mar;20:42-6. doi: 10.1016/j.ijid.2013.12.003. Epub 2014 Jan 6.
Zotero 插件